Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal nalbuphine for prevention of postspinal shivering after knee arthroscopy
PACTR201505001091143Completed
- Sponsor
- Menoufia University Hospitals
- Start
- Jan 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of nalbuphine and bupivacaine in postanesthetic shivering (PAS) (2 arms), sponsored by Menoufia University Hospitals. Primary endpoint: Incidence of shivering. Started Jan 2013; status: completed.
02
Drugs
nalbuphinebupivacaine
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on PACTR201505001091143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201505001091143.